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Abstract 
Peptides deduced from the central hydrophobic region (residues 1.58- 189) of the G protein of bovine and ovine 
respiratory syncytial virus (RSV) and of human RSV subtypes A and B were synthesized. These peptides were used to 
develop ELISAs to measure specifically antibodies against these types and subtypes of RSV. We have evaluated the bovine 
RSV-G peptide in both an indirect ELISA and in a blocking ELISA. Specificity and sensitivity, relative to a routine 
diagnostic ELISA that detects antibodies against the RSV F-protein in bovine sera, were 98% and 92% respectively for the 
indirect peptide-based ELISA, and 98% and 987~ for the blocking peptide-based ELISA. In paired serum samples, rises in 
antibody titer were detected more frequently with the indirect peptide-based ELISA than with the routine F-ELISA. 
Furthermore, the peptide-based G-ELISAs were able to differentiate between antibodies against BRSV and HRSV, and 
between those against BRSV and ORSV. In addition, the indirect peptide-based ELISA was selective for HRSV subtype A 
and B antibodies. This study shows that peptides, corresponding to the central hydrophobic region of the attachment protein 
G of several RSVs. can be used successfully as antigens in highly specific and sensitive immunoassays. 
Kewvrd.sc Respiratory syncytial virus: Peptide: Enzyme immunoassay; Subtype 
1. Introduction 
Human and bovine respiratory syncytial virus 
(RSV) are highly contagious, major pathogens of 
Abbreviations: ELISA, enzyme-linked immunosorbent assay: 
mAb. monoclonal antibody; RSV. respiratory syncytial virus: 
HRPO. horseradish peroxiduse. 
* Corresponding author. Tel.: +31-320-238216; Fax: +31- 
320-238050: e-mail: j.p.m.langedijk@id.dlo.nl. 
young children and calves that cause respiratory 
infections each year (Stott and Taylor, 1985). The 
virus is classified within the Pneumoz~irus genus of 
the Paranzyxo~iridae. Human respiratory syncytial 
virus (HRSV) is the most important causative agent 
of bronchiolitis and pneumonia in infants and young 
children. Approximately 100000 children are hospi- 
talized in the USA each year as a result of RSV 
infection. Respiratory disease can account for up to 
60% of morbidity and for around 60% of mortality 
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in feedlot cattle (Edwards, 1989; Healy et al., 1993). 
Bovine respiratory syncytial virus (BRSV) infections 
are the major cause of respiratory disease in calves 
resulting in high economic losses. Efficacious vac- 
cines against RSV are not available. Because differ- 
ent antigenic subtypes are described for HRSV 
(Johnson et al., 1987) and BRSV (Furze et al.. 
1994), it is important for epidemiological studies and 
vaccine developments to monitor the prevailing sub- 
types in a population. Methods are described for the 
detection of HRSV subtypes using the polymerase 
chain reaction (Cane and Pringle, 1992). However, 
the available immunoassays (Welliver, 1988) are 
based on whole virus or complete proteins that do 
not discriminate between subtypes of HRSV nor 
between different RSV types. 
RSV has two major surface glycoproteins: the 
attachment protein G and the fusion protein F. Be- 
cause the G protein. in contrast to the F protein, is 
highly variable between RSV types, a discriminating 
assay should be based on the G protein. The G 
protein is unique for RSV, and exhibits a limited 
homology between HRSV subtypes (53% amino acid 
homology) (Johnson et al., 1987). or between HRSV 
and ungulate RSV (30% amino acid homology) 
(Lerch et al., 1990). However, within the subtypes 
the amino acid homology is much larger: > 809 
within HRSV-A strains (Cane et al.. 1991); > 907~ 
within HRSV-B strains (Sullender et al., 1991) and 
> 90% within BRSV strains (Mallipeddi and Samal. 
1993). 
The G protein of RSV (RSV-G) is structurally 
and functionally distinct from other viral attachment 
proteins. RSV-G is a type II membrane protein and 
contains about 60% carbohydrate by weight. Approx- 
imately 20% of the carbohydrate moiety are N-lin- 
ked carbohydrates and 80% are O-linked carbohy- 
drates. The latter are linked to the very high number 
of hydroxy amino acids in the protein. The 
ectodomain of the G protein can be described as a 
small central hydrophobic region, devoid of carbohy- 
drates, located between heavily glycosylated mucin- 
like regions (Langedijk et al., 1996). The C-terminal 
part of HRSV-G is an important antigenic region 
(Rueda et al., 1991: Garcia-Barren0 et al.. 1990: 
Sullender. 1995) and according to peptide binding 
studies, a conserved peptide in the central hydropho- 
bic region (residue 174- 188) is ipmunodominant in 
HRSV-G (Norrby et al.. 1987; Akerlind-Stopner et 
al., 1990) and BRSV-G (Langedijk et al., 1996). 
In this study, we demonstrate that the central 
hydrophobic region of the G protein of RSV is an 
important antigenic site. Peptides corresponding to 
the central hydrophobic region of representative RSV 
types and subtypes have been tested in various im- 
munoassays. 
2. Materials and methods 
2.1. Peptide synthesis 
Peptides were selected from the central hydropho- 
bic region of RSV-G that is located between the two 
mucin-like regions. The central hydrophobic regions 
(residues 158-189) of representatives of all cloned 
RSV types and subtypes were synthesized: BRSV-G 
(Lerch et al.. 19901, ORSV-G (Mallipeddi and Samal, 
1993). HRSV-G type A (Wertz et al., 1985). and 
HRSV-G type B (Johnson et al.. 1987). Additionally, 
a peptide corresponding to the immunodominant 
peptide (residues 174- 189) of HRSV-G type A was 
synthesized. 
BRSV: acetyl-N H Q D H N N F Q T L P Y V P C S T C E G N L A C L S L C H I E-amide 
ORSV: acetyl-I Q Q D Y S D F Q I L P Y V P C N I C E G D S A C L S L C Q D R-amide 
HRSV-A: acetyl-K P N N D F H F E V F N F V P C S I C S N N P T C W A I C K R I-amide 
acetyl-S I C S N N P T C W A I C K R I-amide 
HRSV-B: acetyl-K P K D D Y H F E V F N F V P C S I C G N N Q L C K S I C K T I-amide 
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Synthesis of peptides was performed according to 
standard procedures on an Applied Biosystems 430A 
synthesizer using Fastmoc chemistry (Fields et al., 
19911. Oxidised peptide was obtained from /3- 
mercaptoethanol reduced peptide that was slowly 
oxidised by dialysing for 3 days against 1% 
NH,HCO,, which was frequently refreshed. These 
peptides were used as antigens in enzyme linked 
immunosorbent assays (ELISA). The purity of the 
peptides according to HPLC analysis was approxi- 
mately 40%. 
2.2. Serum samples and monoclonal antibodies 
The following serum samples and monoclonal 
antibodies were incorporated in the study. 
2.2.1. Cattle 
Negative field serum samples (n = 40) were ob- 
tained in the summer season from 4-6-month-old 
calves which had no detectable antibodies against 
BRSV for at least 1 month (Van der Poe1 et al., 
19931, as determined by the RSV F-ELISA (Westen- 
brink et al., 1985). 
In addition, negative serum samples (II = 12) were 
obtained from specific-pathogen-free (SPF) calves. 
The calves, obtained by caesarean section. were 
deprived of colostrum, and reared in isolation. 
BRSV-negative serum samples (n = 4). contain- 
ing antibodies directed against either parainfluenza 
virus type 3 (PI-3), bovine herpes virus 1 (BHVl), 
bovine viral diarrhea virus (BVDV) or mycoplasma, 
were also incorporated in this investigation. 
Positive field serum samples (n = 100). that were 
positive in the F-ELISA. were obtained from several 
Dutch farms with a history of BRSV infection (Van 
der Poe1 et al., 1993). In the indirect BRSV-G 
peptide-based ELISA (iG-ELISA). 100 sera were 
tested and in the blocking BRSV-G peptide-based 
ELISA (bG-ELISAl, 97 of these 100 sera were 
tested. 
Paired serum samples (n = 140) from 70 different 
animals were used to test for increases in antibody 
titer. Sera were collected with a one month interval 
in December 1990 and in January 1991 at two 
different Dutch farms (Van der Poe1 et al., 1993). 
Some of these sera (n = 24) were used to distinguish 
between reactivity against the BRSV-G peptide or 
ORSV-G peptide. 
Finally, we tested serum samples (n = 6) that 
reacted non-specifically in the F-ELISA. A serum 
was considered to bind non-specifically if the ab- 
sorbance in the noncoated well was higher than the 
cut-off value. 
2.2.2. Sheep 
Sheep sera (n = 31, positive for RSV in the F- 
ELISA. were obtained from our internal sheep serum 
bank. 
2.2.3. Human 
Human sera (panel 1, II = 23) positive for RSV in 
a complement fixation test, were a kind gift of J.C. 
de Jong of the National Institute of Public Health 
and Environmental Protection (RIVM) in Bilthoven, 
the Netherlands. These sera were used in the ELISAs 
to compare the 16-residue peptide with the 32-re- 
sidue peptide as antigen. 
Paired sera (panel 2, n = 6) of three different 
children (age O-6 months) with respiratory tract 
infection taken in the acute phase and one month 
later were collected. These patients were confirmed 
to have RSV infection by direct immunofluorescence 
on cells from nasopharyngeal washings and virus 
islolation on Hep2 cells. RSV subtype was identified 
using RSV subtype specific monoclonal antibodies 
(92- 1lC for subtype A and 102- 1OB for subtype B, 
Anderson et al., 1985) in immunofluorescence on 
infected Hep2 cells. These sera were used to distin- 
guish between antibody reactivity against the HRSV- 
A G peptide or HRSV-B G peptide. 
2.2.4. Rabbit 
Rabbits (n = 3) were immunized with crude cul- 
ture supematant of HRSV-A (strain Long) and 
HRSV-B (strain 9320) infected cells, respectively. 6 
h before the cytopathic effect developed, culture 
medium was replaced by serum-free medium. In- 
fected Hep2 cells were freeze-thawed after an exten- 
sive cytopathic effect had developed. Cell culture 
was centrifuged at 1600 X g for 10 min and the 
supernatant was used for immunization. Rabbits were 
immunized with 1 ml Freund’s complete adjuvant 
(FCA). mixed 1 : 1 with 1 ml of supernatant. 
2.2.5. Monoclonal antibodies 
Production of a BRSV-G specific monoclonal 
antibody (mAb 20) was performed as previously 
described (Wensvoort et al., 1986). BALB/c mice 
were immunized intraperitoneally with 100 pg BRSV 
(Lelystad strain), grown on embryonic bovine tra- 
cheal cells, mixed with FCA. The RSV specificity of 
mAb 20 was determined using an immunoperoxidase 
monolayer assay (IPMA) as described (Wensvoort et 
al., 1986). In this assay Vero cells infected with 
BRSV (strain Lelystad) were used. Additionally, 
mAb 20 reacted in the BRSV peptide-based iG- and 
bG-ELISA. 
MAbs 2G and 19G specific for the G protein of 
HRSV A, were a kind gift from J.A. Melero, Na- 
tional Centre for Microbiology (Madrid, Spain). 
MAbs 26 and 30. specific for the G protein of HRSV 
subtype B and A, respectively, were a kind gift from 
J. Furze and G. Taylor, AFRC Institute for Animal 
Health, Compton. UK. 
2.3. Respiratory qmcytial l,iru.s spec$c F-ELISA 
2.3.1. Test procedure 
The RSV-specific indirect double antibody sand- 
wich assay, used as a routine diagnostic test in our 
laboratory, was performed essentially as described 
previously (Westenbrink et al., 198.5), except that 
mAbs, instead of horse anti-RSV serum, were used 
as capture antibody. In brief, microtiter plates, coated 
with two mAbs (no. 88953, ID-DLO, Lelystad) di- 
rected against BRSV-F were subsequently incubated 
with bovine RSV antigen, the test serum, rabbit 
anti-bovine immunoglobulin peroxidase (Dakopatts. 
P159) and substrate chromogen solution. Before use, 
and after each incubation step. plates were rinsed six 
times with deionised water containing 0.05% Tween 
80. Dilutions of test sera and reagents were made in 
‘high-salt’ ELISA buffer (8.1 mM Na?HPO,, 2.79 
mM KH,PO,, 0.8 M NaCl, 2.68 mM KCl, 1 mM 
EDTA, 0.05% Tween 80, pH 7.2) containing 4% 
horse serum. BRSV antigen stock solution (no. 
88915, ID-DLO, Lelystad) was diluted l/2 (100 
pi/well) and incubated for 2 h at 37°C. Test sera 
were diluted l/80 (100 PI/well) and incubated for 
1 h at 37°C. Horseradish peroxidase (HRPO) conju- 
gated rabbit anti-bovine immunoglobulin was diluted 
l/2000 (100 pi/well) and incubated for 1 h at 
37°C. The substrate chromogen solution consisted of 
10 mM sodium-phosphate buffer (pH 6.8). 0.1 mM 
EDTA, 0.1% w/v 5-aminosalicylic acid, and freshly 
added 0.005% v/v H,O,. Incubation with substrate 
solution was performed overnight at 4°C. Colour 
development was measured at 450 nm (Titertek Mul- 
tiscan). When sheep, rabbit or human sera were 
tested, absorbance values higher than two times the 
average background value of test sera in control 
wells without antigen, were considered positive. Al- 
though the test has been developed for the detection 
of antibodies specific for BRSV, antibodies against 
all other RSV types can be detected with the test due 
to extensive F protein immune-crossreactivity be- 
tween RSV types and subtypes (Langedijk. unpub- 
lished observations). 
2.4. Illdirect G-peptide ELISA CiG-ELISA) 
2.4. I. Tpst procedure 
The iG-ELISA was based on the test procedure of 
the F-ELISA as described above with the following 
modifications. The antigen was directly coated on to 
the plate. 150 ng of crude oxidized peptide were 
coated per well (high binding capacity flat bottom 
microplate. Greiner) in 100 ~1 carbonate buffer (0.05 
Ml. pH 9.6, 4°C. overnight. The optimal dilution of 
the peptide to coat the ELISA plates was chosen in 
such a manner that a maximum binding was obtained 
as determined in a checkerboard titration. Test sera. 
diluted l/5 (1 /lO in the case of human sera), and 
conjugate were incubated for 1 h at 37°C in ‘low-salt’ 
ELISA buffer (8.1 mM Na,HPO,. 2.79 mM 
KH,PO,. 0.5 M NaCl. 2.68 mM KCl, 1 mM 
Na,EDTA. 0.05% v/v Tween 80, pH 7.2) contain- 
ing 4% horse serum. Subsequently. the test was 
performed as described above. The conjugates used 
in the test were anti-bovine (l/2000). anti-sheep 
(1,’ 1000). and anti-human HRPO (l/ 1000) (Dako- 
patts). When sheep or human sera were tested, ab- 
sorbance values higher than twice the average back- 
ground value of test sera in control wells without 
antigen, were considered positive. Only the large 
bovine serum panels provided the opportunity for an 
accurate cut-off for positivity/negativity. 
2.5. Bloc&g G-peptide ELISA (bG-ELISAI 
2.5. I. Test procedure 
This ELISA for measuring BRSV-specific anti- 
bodies is based on blocking of the interaction of a 
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BRSV-G specific monoclonal antibody (mAb 20) 
with the coated peptide by peptide-specific antibod- 
ies that may be present in the test sample. ELISA 
plates were coated with 30 ng crude oxidized peptide 
per well in 100 ~1 carbonate buffer pH 9.0, 4°C 
overnight. The optimal dilution of the peptide to coat 
the ELISA plates was chosen in such a manner that a 
near maximum binding was obtained as determined 
in a checkerboard titration and that the sensitivity of 
the test was maintained at a high level. Before use, 
and after each incubation step, plates were rinsed six 
times with deionised water containing 0.05% Tween 
80. Plates were subsequently incubated with test 
serum diluted l/2, a HRPO-conjugated monoclonal 
antibody specific for the G-peptide (bovine RSV- 
mAb 20, ID-DLO, Lelystad) diluted l/5000, and 
substrate chromogen solution. Incubation with sub- 
strate solution was performed overnight at 4°C. Test 
sera and conjugate were incubated for 1 h at 37°C in 
‘low-salt’ ELISA buffer containing 4% horse serum. 
Blocking percentages of each test sample was 
calculated using the optical density at 450 nm of 
‘low salt’ ELISA buffer containing 4% horse serum 
as reference (= 0% blocking) according to the fol- 
lowing formula: 
OD. low \.!I1 huttsr+ honeserum - O%,, hnmple 
x 100% 
OD ‘low salt’ buffer+ honeserum 
= blocking percentage of test sample 
3. Results 
3.1. Selection of peptide 
The proposed location of the small central hy- 
drophobic region of RSV-G (Fig. I), the possible 
autonomous folding of this short sequence, the rela- 
tively conserved nature, and the sparse potential 
glycosylation sites makes a peptide representing this 
short region a promising candidate for use as an 
antigen in immunoassays. Besides this structure- 
based approach, empirical methods have shown that 
a part of the central hydrophobic region is an impor- 
tant antigenic site. The single linear immunodomi- 
nant region of BRSV-G as determined by peptide 
binding studies (Langedijk et al., 1996) (residues 
89 
58 
Fig. 1. Schematic structural model of RSV-G protein. The central 
hydrophobic region (residues 158-189) is shown as a grey ellipse. 
Mucin-like regions (residues 56-158. 189-299) are shown with 
potential O-linked glycosylation sites (short horizontal lines) and 
potential N-linked glycosylation sites (branched lines). Black re- 
gions correspond to the transmembrane region and the cytoplas- 
mic region. 
174- 185) and the immunodominant peptide of 
HRSV-G described by Norrby et al. (1987) (residues 
174-188) correspond to the C-terminal half of the 
central hydrophobic region of RSV-G (residues 158- 
189). To check whether the empirically determined 
immunodominant epitope of HRSV-G type A (con- 
tained within the 16-residue peptide 174- 189) has 
the same antigenic characteristics as the predicted 
antigenic site (the 32-residue peptide corresponding 
to the central hydrophobic region 158-189), both 
peptides were tested for their potency to bind spe- 
cific antibodies in an iG-ELISA with the G-peptide 
of HRSV subtype A as antigen. Four times more 
human sera of panel 1 (n = 23) were scored positive 
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in the iG-ELISA based on the 32-residue peptide 
than in the iG-ELISA based on the 16-residue pep- 
tide (data not shown). Although the peptide binding 
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Fig. 2. a: reactivity of bovine sera diluted l/5 in the indirect 
BRSV G peptide ELISA as described in the Materials and meth- 
ods Section 2.4. Negative field serum samples (n = 40) were 
obtained in the summer season from 4-6.month-old calves which 
had no detectable antibodies against BRSV for at least one month 
as determined by routine diagnostic F-protein ELISA. Another set 
of negative serum samples (12 = 12) was obtained from SPF 
calves. Positive field serum samples (n = lOO), that were positive 
in the F-ELISA, were obtained from several Dutch farms with a 
history of BRSV infection Wan der Poe1 et al.. 1993). b: reactiv- 
ity of the same bovine sera, diluted l/80 in the BRSV F-ELISA 
as described in the Materials and methods Section 2.3. 
studies showed that the immunodominant site is 
contained in the 16-mer peptide (Langedijk et al., 
1996, Norrby et al.. 1987). the 32-residue peptide 
corresponding to the central hydrophobic region of 
HRSV-G type A as described in this study (Fig. I), 
is more reactive with human sera when compared 
with the I6-residue peptide. Therefore 32-residue 
peptides, corresponding to the central hydrophobic 
region of the G-protein of BRSV. ORSV, HRSV-A 
and HRSV-B were used as antigens in the im- 
munoassays. 
3.2. iG-ELBA 
The reactivity of different panels of bovine sera in 
the iG-ELISA was compared with the reactivity in 
the routine diagnostic F-ELISA (Fig. 2). Using the 
mean OD of all negative sera (n = 40) plus twice the 
standard deviation ( x + 2 SD = 0.062) as cut-off 
value for negativity, the relative specificity of the 
iG-ELISA was found to be 0.98. Using this cut-off 
value, the sensitivity of the test was determined 
using 100 positive field serum samples from several 
Dutch farms and was found to be 0.92 (92/100) 
when compared to the F-ELISA. Four different sera 
containing antibodies against other microorganisms 
(BHVl, BVDV, PI-3. mycoplasma) were all nega- 
tive in the iG-ELISA (data not shown). Six sera that 
reacted non-specifically in the routine F-ELISA also 
reacted non-specifically in the iG-ELISA (data not 
shown). 
3.3. bG-ELISA 
Blocking percentages of the panels of bovine sera 
were compared in the bG-ELISA (Fig. 3). The sera 
were the same sera that were tested in the iG-ELISA 
and F-ELISA (Fig. 2). When the mean blocking 
percentage of all negative sera (II = 40) ( x + 2 SD 
= 42%) was used as a cut-off value for negativity, 
the specificity relative to the F-ELISA was found to 
be 0.98. The relative sensitivity of the test as deter- 
mined using 97 of the 100 positive field serum 
samples, was found to be 0.98 (95/97). Sera con- 
taining antibodies against other microorganisms 
(BHV-1, BVDV, PI-3, mycoplasma) were all nega- 
tive in the bG-ELISA (data not shown). The six sera 
that reacted non-specifically in the routine F-ELISA 
.I. P.M. Lmgedijk et ul. /Journal of itnmurtologicai Methods 193 i I9961 157- 166 163 
100 
80 
p 6o 
3 
e 40 
20 
0 
s 
_-_ - 
a-- -- 
-& 
-- - 
- _ 
-, -_ ,_ 
negative (40) SPF (12) positive (97) 
Fig. 3. Blocking percentages of different bovine sera diluted l/2 
in the blocking BRSV G peptide ELISA as described in the 
Materials and methods Section 2.5. The same bovine sera were 
used as in the indirect ELISA shown in Fig. 2. Of the 100 positive 
sera 97 samples were rested. 
and in the iG-ELISA, were tested in the bG-ELISA. 
Only one of these six sera blocked significantly 
(750/o), suggesting that the positive serum contained 
BRSV specific antibodies. 
3.4. Detection qf RSV infection 
An antibody titer rise (2 4 X > in paired sera is 
normally regarded as being the result of an infection 
Table I 
Frequency of rise in antibody titer ( 2 4X ), or seroconversion of 
paired bovine sera in different ELISAs 
Farm no. of Frequency for different 
animals ELISAs 
iG-ELISA F-ELISA 
I 21 13/21 9/2l 
I6 Age < I year 25 l7/25 15/25 
Age > I year 24 l2/24 4/24 
Total 70 42/70 28/70 
or reinfection. In 70 paired bovine serum samples, 
seroconversion or at least a fourfold titer rise was 
detected 42 times in the iG-ELISA and 28 times in 
the routine F-ELISA (Table 1). Titer rises were 
detected more frequently in the iG-ELISA than the 
F-ELISA in animals aged > 1 year (Table 1). 
3.5. Type and subtype specif& of peptide-ELBA 
RSV ELISAs based on whole virus contain anti- 
genie proteins which are very conserved. Therefore, 
such ELISAs are not type or subtype specific, which 
means that these assays do not distinguish between 
antibodies directed against human RSV or ungulate 
RSV, and certainly not between antibodies directed 
against HRSV-A and HRSV-B or between BRSV 
and ORSV specific antibodies. Because RSV-G is 
highly variable between RSV types and subtypes, we 
investigated whether peptide-based iG-ELISAs were 
able to recognize type- or subtype-specific antibod- 
ies. ORSV and BRSV are two ungulate RSV types 
which are genetically equally distant compared to the 
distance between HRSV subtype A and HRSV sub- 
type B. The genetic distance based on the amino acid 
sequence of the central hydrophobic region of ORSV 
and BRSV is comparable to the genetic distance 
between HRSV-A and HRSV-B. Therefore, the 
type-specificity of the RSV iG-ELISA can be checked 
with RSV-positive sera of sheep and cattle, which 
most likely can only be infected with ORSV and 
BRSV, respectively. Bovine sera of 24 different 
Table 2 
Reactivity of bovine and ovine sera in the iG-ELISAs based on 
the BRSV-G peptide or the ORSV-G peptide a 
BRSV G 
Titer of bovine serum (n = 24) 
<5 _ 
5 6 
IO 2 
> 40 I6 
ORSV G 
24 
_ 
_ 
_ 
Titer of sheep serum (n = 3) 
<5 3 
IO _ 
40 _ 
_ 
I 
2 
a Doubling dilutions of sera were prepared, starting with a l/5 
dilution. 
Table 3 
Rise in antibody titer, or seroconveraion of paired human sera in 
different ELlSAs ’ 
Patient Subtype h HRSV-A iG-ELISA HRSV-B GELISA 
Tl ’ T2 Tl T7 
1 A <IO 10 < 10 < IO 
2 A IO 80 < IO < IO 
3 B 10 < 10 < IO JO 
’ Doubling dilutions of sem were prepared. atarting with a l/IO 
dilution. 
h Subtyping performed as described in the Materials and method.\. 
’ TI = acute serum, T? = convalescent serum. 
animals, collected at the same time point. and react- 
ing positively in the routine F-ELISA. were tested 
for reactivity in the BRSV iG-ELISA and the ORSV 
iG-ELISA, respectively (Table 2). The bovine sera 
reacted in the BRSV iG-ELISA and not in the ORSV 
iG-ELISA. In addition. three RSV-positive ovine 
sera reacted only in the ORSV iG-ELISA and not in 
the BRSV iG-ELISA (Table 2). Additionally. the 
reactivity of six paired sera of three children showed 
that for two children, a specific titer rise was found 
only in the HRSV-A iG-ELISA and not in the 
HRSV-B iG-ELISA. For one child a specific titer 
rise was found for HRSV-B and not for HRSV-A. 
These specific titer rises corresponded with the in- 
fecting virus subtype (Table 3). Furthermore, sera of 
rabbits immunized with HRSV-A reacted only in the 
HRSV-A iG-ELISA. and the serum of the rabbit 
immunized with HRSV-B reacted only in the HRSV- 
B iG-ELISA. Two HRSV subtype A specific mAbs 
(2G and 19G) reacted only in the HRSV-A iG-ELISA 
and not in the HRSV-B iG-ELISA. MAb 30G re- 
acted 60-fold higher in the HRSV-A iG-ELISA com- 
pared with the HRSV-B iG-ELISA. HRSV subtype 
B specific mAb 26 reacted only in the HRSV-B 
iG-ELISA and not in the HRSV-A iG-ELISA. 
4. Discussion 
The use of peptides as antigens in the serological 
diagnosis of infections has elicited much interest, 
because peptides are cheap and easy to produce in a 
reproducible manner. However, very few peptide- 
based immunoassays have so far been developed 
because of lack of sensitivity. Most peptides that 
have been used in serology represent continuous 
epitopes. It is impossible to detect antibodies against 
complex discontinuous epitopes using small linear 
peptides and it is difficult to predict discontinuous 
epitopes based on the amino acid sequence of a 
protein. In addition. the antigenic surface of large 
globular proteins cannot be mimicked accurately with 
a small linear peptide. Therefore. the prediction of an 
independently folding region in a protein that adopts 
a stable tertiary structure in order to retain its anti- 
genicity, is crucial for the correct design of an 
antigen. In this respect, our hypothetical model of 
the ectodomain of RSV-G (Fig. 1) was very helpful 
for the design of an antigenic peptide (residue IX- 
189). Empirical methods to determine the immun- 
odominant site on BRSV-G and HRSV-G showed 
that the immunodominant site of the peptide was 
located within the C-terminal half of this peptide 
(residue l74- 188) (Langedijk et al.. 1996. Norrby et 
al.. 1987). It has been suggested that a 1%residue 
peptide (residue 174- 188) could bf used for sub- 
type-specific site-directed serology (Akerlind-Stopner 
et al., 1990; Norrby et al., 1987). However, based on 
the observation that the complete 32.residue peptide, 
corresponding to the central hydrophobic region of 
HRSV-G. reacted better as antigen in an ELISA than 
the 16-residue peptide (residues l74- l89), the 32-re- 
sidue peptide was used as antigen in the ELISAs. 
The BRSV iG-ELISA had a sensitivity relative to 
the F-ELISA of 0.90. The low sensitivity compared 
to the routine F-ELISA may be due to (i) a relative 
low antigenicity of BRSV-G compared to that of 
BRSV-F, (ii) low antibody titers of some animals. or 
(iii) some sera may be directed to another, yet un- 
characterized. subtype. In addition to the BRSV 
iG-ELISA. a more sensitive BRSV bG-ELISA was 
developed in which antibody detection was based on 
the capacity to block the reactivity of a G protein 
specific monoclonal antibody against the peptide. A 
sensitivity of 0.98 relative to the routine F-ELISA 
was obtained, and additionally. this type of ELISA is 
less prone to false positive results from non-specific 
sera. 
It is more correct to evaluate the performance of a 
test in the application for which the test is normally 
used. The RSV ELISAs are normally used to detect 
infections or reinfections by measuring BRSV- 
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specific antibody titer rise in paired sera of animals. 
The BRSV iG-ELISA was more sensitive in detect- 
ing reinfections than the F-ELISA. The difference in 
frequency of titer increases seemed to be associated 
with the age of the animal. The iG-ELISA and the 
routine F-ELISA were equally sensitive for the de- 
tection of seroconversion in young calves (age < 1 
year). However, in older cattle (age > 1 year), four 
times more antibody titer increases were detected 
when the iG-ELISA was used. Therefore, the num- 
ber of reinfections may be markedly underestimated 
when titer increases are based on the F-ELISA. The 
different results of both assays may be explained by 
(i) a faster drop of antibody titers against G com- 
pared with that of F after infection, or (ii) by the 
lower antibody response against G compared to that 
against F after the first infection. Consequently, a 
reinfection may induce a more pronounced increase 
in antibodies against G than against F. Therefore, 
G-specific ELISAs, including the peptide ELISAs 
described in this paper, may have an advantage over 
ELISAs based on the F protein. in that more RSV 
reinfections are detected. 
Another advantage of the peptide-based ELISA is 
its type specificity and subtype specificity. Bovine 
and ovine RSV may be considered as two subtypes 
of ungulate RSV. because the genetic distance be- 
tween BRSV and ORSV is comparable to the genetic 
distance between HRSV subtype A and subtype B 
(Mallipeddi and Samal, 1993). Bovine sera, positive 
for RSV in the routine F-ELISA, were positive in the 
BRSV iG-ELISA and negative in the ORSV iG- 
ELISA. Ovine sera, positive for RSV in the routine 
F-ELISA, were positive in the ORSV iG-ELISA and 
negative in the BRSV iG-ELISA. Moreover, sera of 
HRSV-infected children only showed a significant 
titer rise for antibodies against the HRSV subtype 
corresponding to the infecting virus subtype. Poly- 
clonal rabbit sera raised against HRSV-A or HRSV-B 
reacted exclusively with the homologous subtype. 
Furthermore, four mAbs specific for HRSV-G, also 
reacted specifically in one of the subtype-specific 
HRSV iG-ELISAs. An elaborate clinical evaluation 
is required to determine the most appropriate peptide 
based ELISA for routine diagnostic application in 
human and sheep sera. 
In conclusion, a short peptide, which corresponds 
to approximately 0.6% of the total viral genome, can 
be used as the antigen in highly sensitive and spe- 
cific ELISAs. The indirect peptide-based ELISA de- 
tected more reinfections in calves than the F-ELISA 
and can be used for type and subtype specific detec- 
tion of antibodies against RSV. Therefore, this im- 
munoassay should be valuable for epidemiological 
studies. Whenever sequence information becomes 
available about new viral subtypes, a specific peptide 
ELISA could be easily developed. 
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